Deutsch English Français

Contact

EP2155788

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2155788

EP2155788 - CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS [Right-click to bookmark this link]
Status	Patent revoked Status updated on 28.06.2019 Database last updated on 20.12.2024
Most recent event Tooltip	28.06.2019	Revocation of patent	published on 31.07.2019 [2019/31]
	28.06.2019	New entry: Despatch of communication that patent is revoked
Applicant(s)	For all designated states Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 München / DE
	[2012/34]
Former [2010/08]	For all designated states Micromet AG Staffelseestrasse 2 81477 München / DE
Inventor(s)	01 / KLINGER, Matthias Am Buchenstock 24a 82205 Gilching / DE
	02 / RAUM, Tobias Pienzenauerstrasse 110 81025 München / DE
	03 / RAU, Doris Ter-Meer-Strasse 51 82008 Unterhaching / DE
	04 / MANGOLD, Susanne Forstenrieder Allee 140a 81476 München / DE
	05 / KISCHEL, Roman Dr.-Johann-Heitzer-Strasse 36 85757 Karlsfeld / DE
	06 / LUTTERBÜSE, Ralf Fliederstrasse 11 82061 Neuried / DE
	07 / HOFFMANN, Patrick Hohenbirken 26b 83670 Bad Heilbrunn / DE
	08 / KUFER, Peter Am Kapellenacker 13 85368 Moosburg / DE
	[2010/08]
Representative(s)	Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB Ganghoferstraße 68 B 80339 München / DE
	[N/P]
Former [2012/26]	Schiweck, Weinzierl & Koch European Patent Attorneys Landsberger Straße 98 80339 München / DE
Former [2011/08]	Schiweck, Weinzierl & Koch European Patent Attorneys Landsberger Straße 98 80339 München / DE
Former [2010/08]	Weinzierl, Gerhard, et al df-mp Fünf Höfe Theatinerstrasse 16 80333 München / DE
Application number, filing date	08735000.5	03.04.2008
	[2010/08]
	WO2008EP02663
Priority number, date	EP20070006990	03.04.2007 Original published format: EP 07006990
	EP20070006988	03.04.2007 Original published format: EP 07006988
	US20070913668P	24.04.2007 Original published format: US 913668 P
	EP20070020641	22.10.2007 Original published format: EP 07020641
	EP20070020646	22.10.2007 Original published format: EP 07020646
	EP20070020640	22.10.2007 Original published format: EP 07020640
	EP20080004741	13.03.2008 Original published format: EP 08004741
	[2010/08]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2008119566
	Date:	09.10.2008
	Language:	EN
	[2008/41]
	Type:	A2 Application without search report
	No.:	EP2155788
	Date:	24.02.2010
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 09.10.2008 takes the place of the publication of the European patent application.
	[2010/08]
	Type:	B1 Patent specification
	No.:	EP2155788
	Date:	27.06.2012
	Language:	EN
	[2012/26]
Search report(s)	International search report - published on:	EP	08.01.2009
Classification	IPC:	C07K16/28, C07K16/46, C07K16/30, C07K16/32, C07K16/42, // C07K14/705	[2011/50]
	CPC:	C07K16/2809 (EP,US); A61P35/00 (EP); A61P37/00 (EP); A61P37/02 (EP); C07K16/2863 (EP,US); C07K16/30 (EP,US); (+) C07K16/3053 (EP,US); C07K16/32 (EP,US); C07K16/40 (US); C07K16/4291 (EP,US); C07K2317/24 (EP,US); C07K2317/31 (EP,US); C07K2317/33 (EP,US); C07K2317/34 (EP,US); C07K2317/565 (US); C07K2317/622 (EP,US); C07K2317/626 (EP,US); C07K2317/73 (EP,US); C07K2317/90 (EP,US); C07K2317/92 (EP,US); C07K2319/32 (EP,US); C07K2319/43 (EP,US) (-)
	Former IPC [2010/08]	C07K16/28, C07K14/725, C07K16/46, C07K16/30, C07K16/32, C07K16/42
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/08]
Extension states	AL	02.11.2009
	BA	02.11.2009
	MK	02.11.2009
	RS	02.11.2009
Title	German:	KREUZSPEZIESSPEZIFISCHE BISPEZIFISCHE BINDUNGSGLIEDER	[2010/08]
	English:	CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS	[2010/08]
	French:	ÉLÉMENTS DE LIAISON BISPÉCIFIQUES SPÉCIFIQUES D'ESPÈCES CROISÉES	[2010/08]
Entry into regional phase	02.11.2009	National basic fee paid
	02.11.2009	Designation fee(s) paid
	02.11.2009	Examination fee paid
Examination procedure	02.11.2009	Examination requested [2010/08]
	04.01.2010	Amendment by applicant (claims and/or description)
	01.04.2010	Despatch of a communication from the examining division (Time limit: M06)
	11.10.2010	Reply to a communication from the examining division
	07.02.2011	Despatch of a communication from the examining division (Time limit: M06)
	15.08.2011	Reply to a communication from the examining division
	12.12.2011	Communication of intention to grant the patent
	23.04.2012	Fee for grant paid
	23.04.2012	Fee for publishing/printing paid
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 01.04.2010
Opposition(s)	Opponent(s)	01 22.03.2013 26.04.2013 ADMISSIBLE F. Hoffmann-La Roche AG Grenzacherstr. 124 4070 Basel / CH Opponent's representative Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB
		02 26.03.2013 26.04.2013 ADMISSIBLE Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham PA 19044 / US Opponent's representative Goodfellow, Hugh Robin Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		[N/P]
	Former [2019/04]
	Opponent(s)	01 22.03.2013 26.04.2013 ADMISSIBLE F. Hoffmann-La Roche AG Grenzacherstr. 124 4070 Basel / CH Opponent's representative Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB
		02 26.03.2013 26.04.2013 ADMISSIBLE Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham PA 19044 / US Opponent's representative Goodfellow, Hugh Robin Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	Former [2013/18]
	Opponent(s)	01 22.03.2013 F. Hoffmann-La Roche AG Grenzacherstr. 124 4070 Basel / CH Opponent's representative Green, Katherine Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB
		02 26.03.2013 Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham PA 19044 / US Opponent's representative Goodfellow, Hugh Robin Carpmaels & Ransford One Southampton Row London WC1B 5HA / GB
	07.05.2013	Invitation to proprietor to file observations on the notice of opposition
	03.12.2014	Date of oral proceedings
	05.02.2015	Despatch of interlocutory decision in opposition
	05.02.2015	Despatch of minutes of oral proceedings
	12.03.2019	Legal effect of revocation of patent [2019/31]
	11.06.2019	Despatch of communication that the patent will be revoked
Appeal following opposition	14.04.2015	Appeal received No. T0628/15
	15.06.2015	Statement of grounds filed
	12.03.2019	Result of appeal procedure: revocation of the patent
	13.04.2015	Appeal received No. T0628/15
	15.06.2015	Statement of grounds filed
	12.03.2019	Result of appeal procedure: revocation of the patent
	25.03.2015	Appeal received No. T0628/15
	12.06.2015	Statement of grounds filed
	05.11.2015	Invitation to file observations in an appeal (Time limit: M04) [2015/45]
	15.03.2016	Date of receipt of observations in an appeal [2016/12]
	12.03.2019	Result of appeal procedure: revocation of the patent
	12.03.2019	Date of oral proceedings
	27.03.2019	Minutes of the oral proceedings despatched
Fees paid	Renewal fee
	26.03.2010	Renewal fee patent year 03
	21.04.2011	Renewal fee patent year 04
	20.04.2012	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	deleted
	[2013/51]
Former [2013/10]	HR	02.10.2012
Cited in	International search	[Y]WO9901556 (GENENTECH INC [US]) [Y] 10 * sequences 3,6 *;
		[Y]US6037453 (JARDIEU PAULA M [US], et al) [Y] 1-35 * claim 5 *;
		[Y]US2002173629 (JAKOBOVITS AYA [US], et al) [Y] 10 * figures 29,31 *;
		[Y]WO03087131 (GENENTECH INC [US], et al) [Y] 10 * sequences 1,2 *;
		[Y]WO2005056606 (XENCOR INC [US], et al) [Y] 10 * figures 13a,13c *;
		[Y]WO2005061547 (MICROMET AG [DE], et al) [Y] 1-35 * the whole document *;
		[Y]WO2005118635 (NOVIMMUNE SA [CH], et al) [Y] 1-35 * page 3 * * examples 1-5 *;
		[Y]WO2007033230 (NOVIMMUNE SA [CH], et al) [Y] 1-35 * pages 4,12,31 *;
		[PA]WO2007042261 (MICROMET AG [DE], et al);
		[Y] - HAYASHI HIROKI ET AL, "A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells", CANCER IMMUNOLOGY, IMMUNOTHERAPY : CII JUN 2004,, (20040601), vol. 53, no. 6, pages 497 - 509, XP002499717 [Y] 1-35 * page 498 - page 499 * * page 503, column RIGHT - page 504, column LEFT * DOI: http://dx.doi.org/10.1007/s00262-003-0465-9
		[Y] - KORNACKER M ET AL, "THE APOPTOTIC AND PROLIFERATIVE FATE OF CYTOKINE-INDUCED KILLER CELLS AFTER REDIRECTION TO TUMOR CELLS WITH BISPECIFIC AB", CYTOTHERAPY, ISIS MEDICAL MEDIA, OXFORD, (20060201), vol. 8, no. 1, ISSN 1465-3249, pages 13 - 23, XP008077923 [Y] 1-35 * page 14, column RIGHT * * page 15 - page 19 * DOI: http://dx.doi.org/10.1080/14653240500518264
	by applicant	- WILDMAN ET AL., PNAS, (2003), vol. 100, page 7181

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p